Enav Corem-Salkmon
Israel
Research Article
Tumor Necrosis Factor Related Apoptosis Inducing Ligand-conjugated Near IR Fluorescent Iron Oxide/Human Serum Albumin Core-shell Nanoparticles of Narrow Size Distribution for Cancer Targeting and Therapy
Author(s): Itay Levy, Igor Grinberg, Benny Perlstein, Enav Corem-Salkmon and Shlomo MargeItay Levy, Igor Grinberg, Benny Perlstein, Enav Corem-Salkmon and Shlomo Marge
Although much progress has been made in the field of cancer therapy, cancer remains one of the leading causes of death in the western world. Here we have designed and studied a unique type of composite multi-functional near IR (NIR) fluorescent iron oxide (IO) nanoparticles (NPs) of narrow size distribution for tumor targeting and therapy. These NPs were prepared by nucleation followed by controlled growth of thin films of IO onto Cy7-conjugated gelatin nuclei and coated with human serum albumin (HSA) by a thermal precipitation process. The hydrodynamic diameter of these core-shell NPs could be easily controlled by altering the precipitation reaction temperature. For targeting and an anti-cancer effect, we conjugated the Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) cytokine to the surface of the NIR fluorescent IO/HSA NPs via a polyethyl.. View More»
DOI:
10.4172/2157-7439.1000333